CompoAtlas

Chromium GTF

Natural health product licensed in Canada

Licence holder
WN Pharmaceuticals Ltd
NPN or DIN-HM
80005091
Status
Active licence
Licence date
13 February 2008
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Chrome

Source : Produit de chélation de chrome (III) et de protéine végétale hydrolysée (PVH)

500 microgrammesNot calculated

Non-medicinal ingredients

Phosphate de calcium dibasique dihydraté, Stéarate de magnésium, Cellulose, microcristalline

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimé1 Tous les jours

Uses authorised in Canada

Helps the body to metabolize carbohydrates and fats. Provides support for healthy glucose metabolism. Source of mineral, a factor in the maintenance of good health. Source of mineral, a factor in normal growth and development. Source of mineral to support biological functions which play a key role in the maintenance of good health. Mineral supplement. Helps to maintain normal blood glucose levels. Helps to maintain the body's ability to metabolize nutrients. Helps to prevent chromium deficiency.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80005091

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line